NCT01545830View on ClinicalTrials.gov

Metabolic Syndrome and Insulin Resistance at Allina

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

vitamin D3 (cholecalciferol)

Active intervention: 6,000 IUs taken by mouth daily for 6 months Active Comparator: 600 IUs taken by mouth daily for 6 months

Trial Locations (1)

55407

Allina Health, Minneapolis

All Listed Sponsors
lead

Allina Health System

OTHER

NCT01545830 - Metabolic Syndrome and Insulin Resistance at Allina | Biotech Hunter | Biotech Hunter